Check out our most popular compounded medications! Get Started
The Hydrocortisone 10% Phonotophoresis Gel is a clear or tinted gel-like formulation designed to be used in conjunction with ultrasound therapy. This high-viscosity gel serves as a coupling medium to enhance the transmission of ultrasonic waves from the transducer to the skin. Its unique composition not only ensures optimal imaging quality during diagnostic procedures but also improves the efficiency of therapeutic ultrasound waves.
Infused with a 10% concentration of hydrocortisone, this gel is specifically indicated for the treatment of inflammatory skin conditions such as eczema, psoriasis, and dermatitis. The phonotophoresis technique, which involves the use of ultrasound to increase the permeability of the skin and enhance the delivery of the hydrocortisone, allows for targeted anti-inflammatory action directly at the site of the disease. This can lead to improved therapeutic outcomes and relief of symptoms associated with these dermatological conditions.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hydrocortisone 10% Phonotophoresis Gel is a specialized medication designed for use in phonotophoresis, a therapeutic modality that combines the anti-inflammatory and anti-pruritic effects of hydrocortisone with the enhanced delivery provided by ultrasound technology. This gel is typically clear or tinted to ensure ease of application and monitoring during the procedure. The high concentration of hydrocortisone in the gel allows for potent local therapy, targeting areas of inflammation or allergic reactions directly.
The gel serves as a medium for the ultrasound waves, ensuring efficient transmission from the transducer to the skin. This is crucial for both diagnostic imaging and therapeutic interventions, as it allows for clear images and effective delivery of the medication. The ultrasound waves increase the permeability of the skin, facilitating deeper penetration of hydrocortisone into the tissues where it can exert its pharmacological action. This can lead to a reduction in inflammation, edema, and pruritus associated with various dermatological and soft tissue conditions.
Hydrocortisone 10% Phonotophoresis Gel is particularly useful in treating localized inflammatory conditions such as tendonitis, bursitis, and other musculoskeletal disorders where inflammation is a primary concern. It may also be beneficial in certain dermatological conditions that respond to corticosteroids. The use of phonotophoresis can enhance the therapeutic outcomes by delivering the medication more effectively to the affected area, potentially reducing the need for systemic medication and thereby minimizing systemic side effects.
It is important to have a thorough medical evaluation to determine if this treatment is appropriate. Additionally, the procedure should be performed by a trained healthcare professional to ensure safety and efficacy. As with any medication, there may be potential side effects, and these should be discussed with a healthcare provider.
For those interested in utilizing Hydrocortisone 10% Phonotophoresis Gel, or for more information on its formulation and applications, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is equipped to provide detailed guidance and support for both patients and healthcare providers considering this treatment option.
The Hydrocortisone 10% Phonotophoresis Gel is a topical preparation designed to be used in conjunction with ultrasound therapy, known as phonotophoresis. This technique aims to enhance the delivery of hydrocortisone through the skin by using the mechanical effects of ultrasound waves. Hydrocortisone is a corticosteroid that can reduce inflammation and alleviate symptoms associated with various dermatological and soft tissue conditions. When considering the use of this formulation, it is important to be aware of potential drug interactions that may affect the efficacy and safety of the treatment.
Hydrocortisone, when applied topically, has a lower risk of systemic drug interactions compared to oral or parenteral administration. However, certain interactions may still occur. Concurrent use of other topical medications on the same area of skin should be approached with caution. The presence of other topical agents may alter the absorption of hydrocortisone, potentially leading to increased systemic absorption and an elevated risk of systemic side effects. It is advisable to allow an appropriate time interval between the application of different topical medications.
Patients using systemic corticosteroids or those who have conditions that require such treatments should inform their healthcare provider before using Hydrocortisone 10% Phonotophoresis Gel. Although the systemic absorption of hydrocortisone from topical application is generally minimal, the addition of ultrasound may increase penetration, potentially leading to cumulative effects with other corticosteroids. This could increase the risk of systemic side effects such as adrenal suppression, hyperglycemia, and Cushing's syndrome.
Additionally, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or anticoagulant medications, either systemically or topically, may be of concern. The combination of these medications with hydrocortisone could potentially increase the risk of gastrointestinal side effects or bleeding, especially if the patient has a history of ulcers or bleeding disorders. Patients should be monitored for signs of gastrointestinal bleeding and advised to report any unusual symptoms to their healthcare provider.
It is also important to consider the effects of other medical conditions, such as diabetes, hypertension, or infections. Hydrocortisone may alter glucose control, exacerbate hypertension, or mask the signs of infection. Patients with these conditions should be closely monitored during treatment with Hydrocortisone 10% Phonotophoresis Gel.
As with any medication, allergic reactions are possible. Patients with a known allergy to hydrocortisone or any of the excipients in the gel should not use this product. Additionally, the use of occlusive dressings over the area of application can increase systemic absorption and should be avoided unless directed by a healthcare provider.
Lastly, it is essential to consider the impact of other health products, such as herbal supplements, vitamins, and over-the-counter medications, which may interact with hydrocortisone. Patients should disclose all other health products they are using to their healthcare provider to ensure safe and appropriate use of Hydrocortisone 10% Phonotophoresis Gel.
In conclusion, while Hydrocortisone 10% Phonotophoresis Gel is a valuable tool for enhancing the therapeutic effects of ultrasound therapy, careful consideration of potential drug interactions is crucial. Healthcare providers should review the patient's complete medication profile, including prescription drugs, over-the-counter medications, and supplements, to minimize the risk of adverse interactions. If you have any questions or require further information regarding this formulation and its interactions, please reach out to us at Bayview Pharmacy for assistance.
The Hydrocortisone 10% Phonotophoresis Gel is a specialized formulation designed to be used in conjunction with ultrasound therapy, a technique known as phonotophoresis. This method leverages the mechanical energy of ultrasound waves to enhance the delivery of hydrocortisone, a potent corticosteroid, through the skin and into the underlying tissues. The gel serves as a coupling medium that ensures a seamless transmission of these waves from the ultrasound transducer to the patient's skin.
The gel's composition is tailored to minimize air bubbles, which can interfere with the transmission of sound waves, and to maintain the appropriate viscosity that allows for easy spreading and effective ultrasound wave conduction. When the ultrasound waves pass through the gel, they create a series of compression and rarefaction waves in the tissue, which can increase cell membrane permeability and promote deeper penetration of the hydrocortisone.
Hydrocortisone is a corticosteroid that works by reducing inflammation, itching, and swelling. When delivered through phonotophoresis, it can target localized areas of inflammation more effectively. This is particularly beneficial for treating inflammatory conditions such as tendonitis, bursitis, and other musculoskeletal disorders. The high-frequency ultrasound waves can also provide a mild heating effect that helps to soothe pain, relax muscle spasms, and increase blood flow to the affected area, thereby enhancing the therapeutic effects of hydrocortisone.
For patients and prescribers considering the use of Hydrocortisone 10% Phonotophoresis Gel, it is important to understand that this treatment should be administered by a healthcare professional trained in ultrasound therapy. The duration and frequency of treatment will depend on the specific condition being treated and the individual response to therapy. It is also essential to consider contraindications, such as skin infections or sensitivity to hydrocortisone, before proceeding with treatment.
If you have any questions or require further information about the Hydrocortisone 10% Phonotophoresis Gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this formulation.
Hydrocortisone 10% Phonotophoresis Gel is used in conjunction with ultrasound therapy to deliver hydrocortisone, an anti-inflammatory medication, deep into tissues. It is typically utilized to reduce inflammation and associated pain in targeted areas, such as joints or muscles.
Phonotophoresis utilizes ultrasound waves to increase the permeability of the skin, allowing the hydrocortisone in the gel to penetrate deeper into the tissue. The gel acts as a coupling medium, enhancing the transmission of the ultrasound waves from the transducer to the skin.
While primarily used for therapeutic purposes, the Hydrocortisone 10% Phonotophoresis Gel can also be used for diagnostic ultrasound procedures where a clear or tinted gel-like substance is preferred to improve the efficiency of the ultrasound waves and the quality of the imaging.
The gel can be either clear or tinted, based on the preference of the user. A tinted gel may be easier to see during application, ensuring even coverage, while a clear gel might be preferred for a cleaner look.
Unlike topical creams that affect only the surface layers of the skin, phonotophoresis facilitates medication delivery to deeper layers, possibly resulting in quicker and more substantial relief.
The frequency of use for Hydrocortisone 10% Phonotophoresis Gel should be determined by a healthcare professional based on the treatment goals and the patient's individual needs. Always follow the prescribed treatment plan.
Patients with skin conditions that may be exacerbated by ultrasound energy or ingredients in the gel, such as allergies to hydrocortisone, should avoid using this product. Always consult with a healthcare provider before starting treatment.
The gel is compatible with most ultrasound devices designed for therapeutic use. However, it is important to verify compatibility with the specific device manufacturer's recommendations to ensure optimal performance and safety.
Yes, using a proper medium like Hydrocortisone 10% Phonotophoresis Gel is essential for conducting ultrasound therapy effectively. It ensures proper transmission of the ultrasound waves and can aid in the therapeutic delivery of hydrocortisone into the tissue.
As with any medication, the potential for side effects exists. Commonly, side effects may include skin irritation or rash at the site of application. If you experience any unusual symptoms, discontinue use and consult your healthcare provider immediately.
The gel should be stored at room temperature, away from direct sunlight and heat. Keep the container tightly closed when not in use to prevent the gel from drying out.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
